QPT — Quest PharmaTech Balance Sheet
0.000.00%
- CA$8.46m
- CA$9.27m
- 72
- 94
- 72
- 94
Annual balance sheet for Quest PharmaTech, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS/A | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.45 | 0.199 | 0.264 | 0.375 | 0.717 |
Net Total Receivables | 0.011 | 0.033 | 0 | 0.221 | 0.1 |
Prepaid Expenses | |||||
Total Current Assets | 2.89 | 0.281 | 0.288 | 0.622 | 0.836 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.099 | 0.055 | 0.016 | 0.003 | 0 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 4.45 | 176 | 91 | 26.8 | 24.5 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 20.9 | 0.335 | 0.623 | 1.11 | 1.32 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 19.8 | 0.389 | 0.623 | 1.11 | 1.32 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -15.3 | 175 | 90.4 | 25.7 | 23.2 |
Total Liabilities & Shareholders' Equity | 4.45 | 176 | 91 | 26.8 | 24.5 |
Total Common Shares Outstanding |